Design and synthesis of naturally-inspired SARS-CoV-2 inhibitors

被引:3
|
作者
Hassan, Haitham [1 ]
Chiavaralli, Jeanne [2 ]
Hassan, Afnan [3 ,4 ]
Bedda, Loay [3 ,4 ]
Krischuns, Tim [5 ]
Chen, Kuang-Yu [5 ]
Li, Alice Shi Ming [6 ]
Delpal, Adrien [7 ]
Decroly, Etienne [7 ]
Vedadi, Masoud [6 ,8 ]
Naffakh, Nadia [5 ]
Agou, Fabrice [2 ]
Mallart, Sergio [1 ]
Arafa, Reem K. [3 ,4 ]
Arimondo, Paola B. [1 ]
机构
[1] Univ Paris Cite, Inst Pasteur, Dept Struct Biol & Chem, CNRS,UMR 3523,Chem4Life,Epigenet Chem Biol, F-75015 Paris, France
[2] Univ Paris Cite, Inst Pasteur, Ctr Technol Resources & Res C2RT, CNRS,UMR 3523,Chem4Life,Chemogen & Biol Screening, F-75015 Paris, France
[3] Drug Design & Discovery Lab, Zewail City Sci & Technol, Cairo 12578, Egypt
[4] Univ Sci & Technol, Biomed Sci Program, Zewail City Sci & Technol, Cairo 12578, Egypt
[5] Univ Paris Cite, Inst Pasteur, Unit Biol ARN & Virus Influenza, CNRS,UMR3569, F-75015 Paris, France
[6] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada
[7] Marseille Univ, CNRS, UMR7257, AFMB Aix, Marseille, France
[8] QBI COVID 19 Res Grp QCRG, San Francisco, CA USA
来源
RSC MEDICINAL CHEMISTRY | 2023年 / 14卷 / 03期
关键词
D O I
10.1039/d2md00149g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A naturally inspired chemical library of 25 molecules was synthesised guided by 3-D dimensionality and natural product likeness factors to explore a new chemical space. The synthesised chemical library, consisting of fused-bridged dodecahydro-2a,6-epoxyazepino[3,4,5-c,d]indole skeletons, followed lead likeness factors in terms of molecular weight, C-sp(3) fraction and Clog P. Screening of the 25 compounds against lung cells infected with SARS-CoV-2 led to the identification of 2 hits. Although the chemical library showed cytotoxicity, the two hits (3b, 9e) showed the highest antiviral activity (EC50 values of 3.7 and 1.4 mu M, respectively) with an acceptable cytotoxicity difference. Computational analysis based on docking and molecular dynamics simulations against main protein targets in SARS-CoV-2 (main protease M-pro, nucleocapsid phosphoprotein, non-structural protein nsp10-nsp16 complex and RBD/ACE2 complex) were performed. The computational analysis proposed the possible binding targets to be either M-pro or the nsp10-nsp16 complex. Biological assays were performed to confirm this proposition. A cell-based assay for M-pro protease activity using a reverse-nanoluciferase (Rev-Nluc) reporter confirmed that 3b targets M-pro. These results open the way towards further hit-to-lead optimisations.
引用
收藏
页码:507 / 519
页数:13
相关论文
共 50 条
  • [1] Repurposing and computational design of PARP inhibitors as SARS-CoV-2 inhibitors
    Rampogu, Shailima
    Jung, Tae Sung
    Ha, Min Woo
    Lee, Keun Woo
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [2] Repurposing and computational design of PARP inhibitors as SARS-CoV-2 inhibitors
    Shailima Rampogu
    Tae Sung Jung
    Min Woo Ha
    Keun Woo Lee
    Scientific Reports, 13
  • [3] Design, Synthesis, Evaluation, and Molecular Dynamics Simulation of SARS-CoV-2 Mpro Inhibitors
    Yang, Qinghua
    Zong, Keli
    Zhao, Xu
    Zhang, Fenghua
    Li, Fei
    Li, Xingzhou
    ACS MEDICINAL CHEMISTRY LETTERS, 2025,
  • [4] Design, synthesis and evaluation of inhibitors of the SARS-CoV-2 nsp3 macrodomain
    Sherrill, Lavinia M.
    Joya, Elva E.
    Walker, AnnMarie
    Roy, Anuradha
    Alhammad, Yousef M.
    Atobatele, Moriama
    Wazir, Sarah
    Abbas, George
    Keane, Patrick
    Zhuo, Junlin
    Leung, Anthony K. L.
    Johnson, David K.
    Lehtio, Lari
    Fehr, Anthony R.
    Ferraris, Dana
    BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 67
  • [5] Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity
    Flury, Philipp
    Breidenbach, Julian
    Krueger, Nadine
    Voget, Rabea
    Schaekel, Laura
    Si, Yaoyao
    Krasniqi, Vesa
    Calistri, Sara
    Olfert, Matthias
    Sylvester, Katharina
    Rocha, Cheila
    Ditzinger, Raphael
    Rasch, Alexander
    Poehlmann, Stefan
    Kronenberger, Thales
    Poso, Antti
    Rox, Katharina
    Laufer, Stefan A.
    Mueller, Christa E.
    Guetschow, Michael
    Pillaiyar, Thanigaimalai
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024, 7 (02) : 493 - 514
  • [6] Computational Design of Miniproteins as SARS-CoV-2 Therapeutic Inhibitors
    Jawad, Bahaa
    Adhikari, Puja
    Cheng, Kun
    Podgornik, Rudolf
    Ching, Wai-Yim
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (02)
  • [7] Inhibitors of SARS-CoV-2 PLpro
    Calleja, Dale J.
    Lessene, Guillaume
    Komander, David
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [8] Design, synthesis, and biological evaluation of dithiocarbamate derivatives as SARS-CoV-2 M pro inhibitors
    Peng, Jin-Qi
    Xiao, Ya-Qi
    Long, Jiao
    Zhang, Shuang-Shuang
    Zhu, Yuan-Yuan
    Gu, Shuang-Xi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 114
  • [9] De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
    Cao, Longxing
    Goreshnik, Inna
    Coventry, Brian
    Case, James Brett
    Miller, Lauren
    Kozodoy, Lisa
    Chen, Rita E.
    Carter, Lauren
    Walls, Alexandra C.
    Park, Young-Jun
    Strauch, Eva-Maria
    Stewart, Lance
    Diamond, Michael S.
    Veesler, David
    Baker, David
    SCIENCE, 2020, 370 (6515) : 426 - +
  • [10] Fragment-based design of SARS-CoV-2 Mpro inhibitors
    Divya M. Teli
    Bansari Patel
    Mahesh T. Chhabria
    Structural Chemistry, 2022, 33 : 2155 - 2168